These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34100396)

  • 1. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.
    Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK
    Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.
    Guillaume P; Rupp T; Froget G; Goineau S
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
    Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L
    Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice.
    Khafaji AWM; Al-Zubaidy AAK; Farhood IG; Salman HR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):6231-6248. PubMed ID: 38446218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects.
    Mousa AM; Alhumaydhi FA; Abdellatif AAH; Abdulmonem WA; AlKhowailed MS; Alsagaby SA; Al Rugaie O; Alnuqaydan AM; Aljohani ASM; Aljasir M; Alwashmi ASS; Soliman KEA; Yosof MYR; Elsheikh SY; Babiker AY; Alsuhaibani SA; Hegazy AMS; Seleem HS
    Cutan Ocul Toxicol; 2022 Mar; 41(1):33-42. PubMed ID: 34749565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of
    Emami Z; Shobeiri SS; Khorrami R; Haghnavaz N; Rezaee MA; Moghadam M; Pordel S; Sankian M
    Mediators Inflamm; 2024; 2024():5821996. PubMed ID: 39045230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
    Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
    Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
    Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model.
    Gómez-Chávez F; Cedillo-Peláez C; Zapi-Colín LA; Gutiérrez-González G; Martínez-Torres I; Peralta H; Chavez-Galan L; Avila-Calderón ED; Contreras-Rodríguez A; Bartolo-Aguilar Y; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis.
    Chen J; Liu Y; Yin N; Zhao M; Sun X; Zhang Y; Wang Z
    Int Immunopharmacol; 2024 May; 132():111923. PubMed ID: 38565041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat.
    Chatterjee O; Sur D
    J Basic Clin Physiol Pharmacol; 2024 Jan; 35(1-2):45-52. PubMed ID: 38341859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
    Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
    Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Profiling for Unveiling Mechanisms of Kushenol F against Imiquimod-Induced Psoriasis with UHPLC/MS Analysis.
    Yang X; Cheng J; Yin X; Ao T; He X; Yang Y; Lin Y; Chen Z
    Molecules; 2024 May; 29(11):. PubMed ID: 38893287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-psoriatic potential of Solanum xanthocarpum stem in Imiquimod-induced psoriatic mice model.
    Parmar KM; Itankar PR; Joshi A; Prasad SK
    J Ethnopharmacol; 2017 Feb; 198():158-166. PubMed ID: 28052238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
    Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
    Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.